Drawing for SCAGE

USPTO serial 76346743

SCAGE

Reviewed by CopyMark Law Group

Reg. 3081096Status 710
Filing date
Status date
Registration date
Apr 18, 2006
Examiner
JENKINS JR, CHARLES L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SCAGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven L. Highlander

STEVEN L HIGHLANDER FULBRIGHT & JAWORSKI LLP600 CONGRESS AVE STE 2400AUSTIN, TX 78701UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations, namely, buffer, polypeptides, nucleic acids for use in scientific experiments; chemical agents for characterizing and examination of diseases, particularly of tumors, coronary heart diseases, particularly restenosis, minimal residual diseases, infectious diseases, autoimmune diseases for scientific purposes; chemical agents for characterizing and examination of eukaryotic cells, namely, animal cells, particularly mammalian cells and human cells, green plant cells, fungi cells, rhodophyta cells, alveolate cells, stramenopiles cells, other protist cells, particularly kinetoplastida and amoeboflagellata, cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, particularly from amniotic fluid, liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells for scientific use; eukaryotic cell culture lines, namely, animal cell culture lines, particularly mammalian cell culture lines and human cell culture lines, green plant cell culture lines, fungi cell culture lines, rhodophyta cell culture lines, alveolate cell culture lines, stramenopiles cell culture lines, other protist cell culture lines, particularly kinetoplastida and amoeboflagellata cell culture lines for scientific purposes; cultures of microorganisms for scientific purposes; nucleic acids for scientific purposesSECTION 8 - CANCELLED—
005Medical diagnostic chemical agents for characterizing and examination of diseases, namely, tumors, coronary heart diseases, particularly restenosis, minimal residual diseases, infectious diseases, autoimmune diseases; pharmaceutical preparations for the treatment of tumors, coronary heart diseases, particularly restenosis, minimal residual diseases, infectious diseases, autoimmune diseases and veterinary preparations for the treatment of pets and farm animals, namely pigs, dogs, cats, ferrets, hoofed animals, particularly horses, cattle, sheep, asses and mules, birds, particularly poultry, particularly chickens, ducks, turkeys and gooses, pigeons, parrots and budgerigars, fishes, small animals, particularly hares, rabbits, hamsters, mice, rats and guinea pigs, reptiles, particularly snakes, frogs, turtles, crocodiles and lizards; pharmaceutical preparations for diagnosis and analysis of tumors; coronary heart diseases, particularly restenosis, minimal residual diseases, infections diseases, autoimmune diseases; pharmaceutical preparations for diagnosis and analysis of eukaryotic cells, mammalian cells and human cells, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, particularly amniotic fluid, from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells of differentiated stages from specific cells; eukaryotic cell culture lines, namely, animal cell culture lines, particularly mammalian cell culture lines and human cell culture lines, green plant cell culture lines, rhodophyta cell culture lines, alveolate cell culture lines, stramenopiles cell culture lines, protist cell culture lines, fungi cell culture lines for medical purposes; cultures of microorganisms for medical purposes; nucleic acids for medical purposesSECTION 8 - CANCELLED—
009Diagnostic and testing apparatus and instruments, namely, syringe, needle, biopsy needle, array, particularly DNA-array, array reader, scanner, imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge tubes, filter, rotator, mixer, beads, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices for scientific purposes; diagnostic and testing apparatus and instruments, namely, syringe, needle, biopsy needle, array, particularly DNA-array, array reader, scanner, imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge tubes, filter, rotator, mixer, beads, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices for the development of medicaments, for the identification of expressed genes, particularly abnormal expressed genes; Diagnostic and testing apparatus and instruments for the analysis of the gene expression patterns of single cells and cell culture lines, mammalian cells and human cells, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, from amniotic fluid, liquor, blood, lymph, urine or bowel movements, of stem cells, cloned single cells or differentiated stages from specific cellsSECTION 8 - CANCELLED—
010Medical diagnostic instruments, namely, syringe, needle, biopsy needle, array, particularly DNA-array, array reader, scanner, Imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge tubes, filter, rotator, mixer, beads, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices for diagnosing tumors, coronary heart diseases, particularly restenosis, minimal residual diseases, infectious diseases, autoimmune diseases; diagnostic and testing apparatus for medical purposes, namely, syringe, needle, biopsy needle, array, particularly DNA-array, array reader, scanner, imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge, tubes, filter, rotator, mixer, beads, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices, for testing for eukaryotic cells, cells of microscopic small biopsies, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids from amniotic fluid, liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells of human tissues; medical diagnostic and testing apparatus, namely syringe, needle, biopsy-needle, array, particularly DNA-array, array reader, scanner, imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge tubes, filter, rotator, mixer, bead, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices for testing animal cells for veterinary useSECTION 8 - CANCELLED—
042Medical services; scientific and industrial research in the field of molecular biology, bio-technology, genetics, medicine and pharmacology; medical services, namely, diagnosis of pathogenesis of animal and human diseases, cell differentiation of stem cells and other progenitor cells, steps in the development from micrometastatic cells to metastatic cells, characterization of the differentiated stages from specific cells; identification of target structures for the development of medicaments; medical services for the determination of the influence of various substances on the cell growth, proliferation, differentiation and secretion of molecules in various cell types, characterization of the differentiation of nerve cells; characterization of intracellular signal transduction pathways; determination of the influence of the co-culture of cell lines on the cell growth, proliferation, differentiation and secretion of molecules in various cell types and on differential gene expression; medical services and veterinary medicine; Development of pharmaceuticals; laboratory research in the field of identification of expressed genes, namely, abnormal expressed genes, analysis of the gene expression pattern, single cells and cell culture lines in human and mammalian cells; laboratory research in the field of cells of microscopic small biopsies of animal and human tissues, cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids from amniotic fluid, liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells, differentiated stages from specific cells; Development of new technology for others in the field of scientific and industrial researchSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 23, 2012C8..CANCELLED SEC. 8 (6-YR)—
Apr 18, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 14, 2006DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jan 27, 2006IUCNNOTICE OF ALLOWANCE CANCELLED—
Jan 9, 2006MAILPAPER RECEIVED—
Nov 16, 2005FAXXFAX RECEIVED—
Sep 7, 2005FAXXFAX RECEIVED—
Aug 11, 2005FAXXFAX RECEIVED—
Aug 3, 2005EX2GSOU EXTENSION 2 GRANTED—
Jul 22, 2005EXT2SOU EXTENSION 2 FILED—
Jul 22, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 18, 2005EX1GSOU EXTENSION 1 GRANTED—
Jan 18, 2005EXT1SOU EXTENSION 1 FILED—
Jan 18, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 10, 2005MAILPAPER RECEIVED—
Jul 27, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 4, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 14, 2004NPUBNOTICE OF PUBLICATION—
Feb 11, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 20, 2003MAILPAPER RECEIVED—
Nov 17, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 5, 2003CFITCASE FILE IN TICRS—
May 22, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 17, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2003MAILPAPER RECEIVED—
Jan 3, 2003CNSLLETTER OF SUSPENSION MAILED—
Oct 25, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 25, 2002MAILPAPER RECEIVED—
Oct 22, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2002DOCKASSIGNED TO EXAMINER—
Jan 22, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—

Frequently asked questions

Related guidance